Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia. uri icon

authors

  • Roberts, Angela C
  • Rademaker, Alfred W
  • Salley, Elizabeth Ann
  • Mooney, Aimee
  • Morhardt, Darby
  • Fried-Oken, Melanie
  • Weintraub, Sandra
  • Mesulam, Marsel
  • Emily Rogalski, PhD

publication date

  • January 1, 2022

published in